Trial intelligence / Profile preview

Clonidine adjunctive therapy versus placebo in bipolar disorder manic episode

IRCT20120215009014N295Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in bipolar disorder (BD) comparing Clonidine plus standard treatment with Placebo plus standard treatment (2 arms). Started Sep 2019; status: completed.

02

Drugs

clonidine
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on IRCT20120215009014N295.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N295.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call